Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: Vertex Pharmaceuticals Incorporated
February 2, 2026
Vertex Pharmaceuticals Incorporated
Orphan Drug Designation
treatment of myasthenia gravis
Disease Area:
Rare Disease
Source
Source
January 22, 2026
Vertex Pharmaceuticals Incorporated
Orphan Drug Designation
Treatment of membranous nephropathy
Disease Area:
Rare Disease
Source
Source
Scroll to Top
